In a significant scientific breakthrough, researchers have uncovered direct evidence of how HIV, the virus that causes AIDS, invades and infects healthy cells. This finding sheds new light on the mechanisms by which HIV enters and replicates within host cells, offering important insights for the development of novel treatment strategies.

Using advanced imaging techniques, including cryo-electron microscopy (cryo-EM), researchers were able to visualize the precise molecular interactions that occur during HIV's entry into human immune cells known as CD4+ T cells. These cells play a crucial role in the body's defense against infections, making them a primary target for HIV.

The study revealed that HIV utilizes a specific protein on its surface, called gp120, to bind to a receptor protein (CD4) on the surface of CD4+ T cells. This binding triggers a conformational change in gp120, exposing another region of the virus known as gp41.

Gp41 then interacts with a co-receptor protein, either CCR5 or CXCR4, which are also present on the surface of CD4+ T cells. This interaction enables the virus to fuse its outer membrane with the cell membrane, creating a pore through which the viral genetic material (RNA) enters the host cell.

Once inside the cell, the viral RNA is reverse transcribed into DNA and integrated into the host cell's own genetic material. This integration allows the virus to replicate and produce new viral particles, further infecting and destroying CD4+ T cells and weakening the body's immune system.

The direct visualization of these molecular interactions provides crucial information for understanding the initial steps of HIV infection, which could lead to the development of new therapeutic interventions. By targeting specific proteins involved in the viral entry process, researchers may be able to block HIV's ability to infect and spread, ultimately contributing to the fight against AIDS.